Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction. (2021)
Attributed to:
Use of nanoparticles to deliver growth signals to the placenta
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13111778
PubMed Identifier: 34834193
Publication URI: http://europepmc.org/abstract/MED/34834193
Type: Journal Article/Review
Volume: 13
Parent Publication: Pharmaceutics
Issue: 11
ISSN: 1999-4923